Agilent Technologies Denmark Aps

Beskrivelse af virksomhedens væsentligste aktiviteter

Principal activities
Agilent Technologies Denmark ApS, hereinafter referred to as “company”, operates as a reseller of products/services covering life sciences, diagnostics and applied chemicals markets. A major part of the products/services range is purchased from group companies within and outside of Denmark. There is no significant change in the company’s activities or financial and economic conditions.

Beskrivelse af udviklingen i virksomhedens aktiviteter og økonomiske forhold

Developments during the year
The management continues to work towards achieving operational efficiencies through process realignment and development. The company together with other group companies continues to pursue new products, markets and opportunities.

Omtale af betydningsfulde hændelser, som er indtruffet efter regnskabsårets afslutning

Significant events after the end of the financial year
Apart from the abovementioned developments, the Board of Directors and Executive Management are not aware of any event after 31st October 2023 that may have a material impact on the company’s financial position.

Beskrivelse af virksomhedens forventede udvikling

Future expectations
The management recognizes the challenges of the current economic environment but expects a profitable fiscal ahead. The corporate guidance for worldwide Agilent group earnings is publicly available in our first quarter earnings report released on 27th Feb 2024. It is Agilent’s group policy to release estimates of future earnings at a consolidated worldwide level. With respect to the Denmark based company the revenues are estimated to be in a broad range from DKK 900M to 1,100M based on past business trends. The net profits are broadly estimated to be in the range of DKK 20-60M.